CoChat

CRISPR in the North American popular press

Open access

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

PURPOSE: CRISPR is often called one of the century's most important discoveries and is commonly discussed in terms of its momentous potential impacts. This study analyzed how CRISPR is discussed in the North American popular press, including how it is defined, and which benefits and risks/concerns are attributed to the technology. METHODS: Using the Factiva database, we identified 228 relevant, nonduplicated articles containing either "CRISPR" or "C.R.I.S.P.R.," published in popular US and Canadian news sources between 1 January 2012 and 12 July 2017. Content analysis was performed on the articles. RESULTS: CRISPR is most often discussed in the context of human health (83.8%), compared with animals (26.3%) and plants (20.6%). Nearly all articles (96.1%) presented CRISPR's potential benefits; 61.4% of articles presented CRISPR-related risks/concerns, the vast majority of which focused on the uncertainty surrounding CRISPR, specifically with respect to germline modifications. CONCLUSIONS: Overall, the discourse suggests a strong promotion of CRISPR, but an element of caution is also evident. Technical as well as ethical, legal, and social risks/concerns play a prominent role. This media portrayal of CRISPR might help facilitate more sophisticated and balanced policy responses, where the scientific potential of the technology is highlighted alongside broader social considerations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41436-019-0482-5

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 CRISPR benefits and risks/concerns in North American popular press articles (n = 228). (a) Overall presence of CRISPR benefits and risks/concerns in North American popular press articles (n = 228). (b) Specific CRISPR benefits and risks/concerns in North American popular press articles (n = 228).
Fig. 1 CRISPR benefits and risks/concerns in North American popular press articles (n = 228). (a) Overall presence of CRISPR benefits and risks/concerns in North American popular press articles (n = 228). (b) Specific CRISPR benefits and risks/concerns in North American popular press articles (n = 228).CC BY-NC-ND · PubMed Central
Fig. 2 Tone of the articles with regards to CRISPR (n = 228).
Fig. 2 Tone of the articles with regards to CRISPR (n = 228).CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 34

Metadata

Authors
Marcon, A., Master, Z., Ravitsky, V., & Caulfield, T.
Affiliations
  • University of Alberta (CA)
  • Mayo Clinic (US)
  • Université de Montréal (CA)
Corresponding author
Caulfield, Timothy
Venue
Genetics in Medicine
Publisher
Elsevier BV
Published
2019-10
Volume
21
Issue
10
Pages
2184-2189
ISSN
1098-3600 (ISSN-L)
OpenAlex
W2936337436
Cited by
34
References
15
Citations by year
2026: 4 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 7 · 2021: 6 · 2020: 4 · 2019: 2
FWCI
1.57
Type
journal article
Language
en
Open access
Licence
Locations
  • Genetics in Medicine (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
Genome Canada
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Social Sciences › Communication › News Media Framing and Political Communication
  • Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
Keywords
CRISPR, media coverage, popular press, public perception, science communication, germline editing, ethical, legal and social implications, health benefits, risk perception, science policy
MeSH terms
Gene Editing, Animals, Humans, North America, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CRISPR in the North American popular press. https://app.cochat.ai/papers/10.1038/s41436-019-0482-5
The paper
Marcon, A., Master, Z., Ravitsky, V., & Caulfield, T. (2019). CRISPR in the North American popular press. Genetics in Medicine. https://doi.org/10.1038/s41436-019-0482-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.